Skip to main content
Liana Fraenkel, MD, Rheumatology, Pittsfield, MA

LianaFraenkelMDMPH

Rheumatology Pittsfield, MA

Professor, Internal Medicine, Yale University School of Medicine

Dr. Fraenkel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Fraenkel's full profile

Already have an account?

  • Office

    777 North St
    Ste 203
    Pittsfield, MA 01201
    Phone+1 413-499-8551
    Fax+1 413-442-9161

Education & Training

  • Boston University Medical Center
    Boston University Medical CenterFellowship, Rheumatology, 1994 - 1998
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1990

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1997 - 2025
  • CT State Medical License
    CT State Medical License 1998 - 2019
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow (FACR) American College of Rheumatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Nonsteroidal Anti-Inflammatory Drugs vs Cognitive Behavioral Therapy for Arthritis Pain  
    Liana Fraenkel, Lisa Suter, Catherine Najem, JAMA Internal Medicine
  • A Qualitative Exploration of Triangulated Shared Decision Making in Rheumatoid Arthritis  
    Betty Hsiao, Liana Fraenkel, Arthritis Care & Research
  • Persistently Frequent Emergency Department Utilization Among Persons with Systemic Lupus Erythematosus  
    Lisa Gale Suter, Liana Fraenkel, Arthritis Care & Research
  • Join now to see all

Authored Content

  • Nonsteroidal Anti-Inflammatory Drugs vs Cognitive Behavioral Therapy for Arthritis PainJuly 2020

Press Mentions

  • All or Something: Experts Debate LDA vs. Remission as a Target in Rheumatoid Arthritis
    All or Something: Experts Debate LDA vs. Remission as a Target in Rheumatoid ArthritisApril 19th, 2022
  • New Medication Guidelines for Treating Rheumatoid Arthritis Released
    New Medication Guidelines for Treating Rheumatoid Arthritis ReleasedJuly 9th, 2021
  • New ACR Rheumatoid Arthritis Guideline: Emphasis on Methotrexate
    New ACR Rheumatoid Arthritis Guideline: Emphasis on MethotrexateJune 28th, 2021
  • Join now to see all

Grant Support

  • Improving Decision Making In Patients With Rheumatic DiseaseNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
  • Eliciting Patient Treatment Preferences For OsteoporosisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2008

Professional Memberships